Vivos Therapeutics, Inc. Paid-in-Kind Interest
Vivos Therapeutics, Inc. (VVOS) reported Paid-in-Kind Interest of $140.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-05-20
- Vivos Therapeutics, Inc. paid-in-kind interest for the quarter ending 2026-03-31 was $140.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 9 month |
|---|---|---|
| 2026-03-31 | $140.00K 10-Q · filed 2026-05-20 | |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |